Movement Alert｜GENSCRIPT B-1K Falls 6.57% in Regular Trading, UBS Downgrade to Neutral Weighs on Sentiment

Market Focus10-23

On October 23, GENSCRIPT B-1K fell 6.57% in Regular Trading, trading at HK$30.2, with turnover of HK$66.87 million.

The clearest catalyst was a fresh rating action: UBS downgraded the stock to Neutral and set a target price of RMB27, which directly pressured near-term risk appetite.

The downgrade came after a strong run supported by improving CARVYKTI sales, institutional accumulation, and enthusiasm around AI-enabled life sciences tools. Earlier disclosures showed CARVYKTI generated trade sales of about US$710 million in the September quarter, taking the first nine months to about US$1.964 billion, up 47.4% year on year, while FMR LLC and Pandanus Partners had recently increased holdings. Against that backdrop, the latest broker downgrade appears to have outweighed prior positives and triggered profit-taking.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment